Figure1 (Figure1)
Lansoprazole Capsule, Delayed Release
Product Images NDC 71335-2957
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 71335-2957). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure2 (Figure2)
This text provides information about the mean severity of night heartburn by study day for evaluable patients, using a scale where '@' indicates severe, '2' indicates moderate, '1' indicates mild, and '0' indicates none. It also mentions the measurement of the severity of night heartburn over days from the start of the treatment.*
Label (Lbl713352957)
This is a description for Lansoprazole delayed-release capsules containing 15 mg USP (as enteric coated pellets). Each capsule is imprinted with "RDY" and "Dwg LAN" for identification. It is recommended to store the capsules at 20-25°C (68-77°F), dispense them with a Medication Guide to each patient, and protect them from moisture. The package includes 30 capsules and is manufactured by Dr. Reddys Laboratories Ltd. Dispense in a USP tight container and do not accept if the seal is broken or missing. Pharmacist should scan the QR code for full prescribing information.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
